دورية أكاديمية

IMI-Management and Investigation of High Myopia in Infants and Young Children.

التفاصيل البيبلوغرافية
العنوان: IMI-Management and Investigation of High Myopia in Infants and Young Children.
المؤلفون: Flitcroft I; Children's Health Ireland (CHI) at Temple Street, Dublin, Ireland.; Centre for Eye Research Ireland, Technological University of Dublin, Dublin, Ireland., Ainsworth J; Birmingham Children's Hospital, Steelhouse Lane Birmingham, United Kingdom., Chia A; Singapore National Eye Center, Singapore., Cotter S; Southern California College of Optometry, Marshall B Ketchum University, Fullerton, California, United States., Harb E; Wertheim School Optometry and Vision Science, Berkeley, California, United States.; University of California - San Francisco, School of Medicine, San Francisco, California, United States., Jin ZB; Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China., Klaver CCW; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.; Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland., Moore AT; University of California - San Francisco, School of Medicine, San Francisco, California, United States., Nischal KK; UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States., Ohno-Matsui K; Tokyo Medical and Dental University, Tokyo, Japan., Paysse EA; Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, United States., Repka MX; Wilmer Eye Institute, The John Hopkins University School of Medicine, Baltimore, Maryland, United States., Smirnova IY; Ophthalmology Center Glazka, Novosibirsk, Russia., Snead M; Department of Vitreoretinal Research, John van Geest Centre for Brain Repair, University of Cambridge, United Kingdom., Verhoeven VJM; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands., Verkicharla PK; L V Prasad Eye Institute, Hyderabad, India.
المصدر: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2023 May 01; Vol. 64 (6), pp. 3.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Association For Research In Vision And Ophthalmology (Arvo) Country of Publication: United States NLM ID: 7703701 Publication Model: Print Cited Medium: Internet ISSN: 1552-5783 (Electronic) Linking ISSN: 01460404 NLM ISO Abbreviation: Invest Ophthalmol Vis Sci Subsets: MEDLINE
أسماء مطبوعة: Publication: Brookline Ma : Association For Research In Vision And Ophthalmology (Arvo)
Original Publication: St. Louis, Mosby.
مواضيع طبية MeSH: Myopia*/diagnosis, Humans ; Infant ; Child, Preschool ; Child ; Refraction, Ocular ; Eye ; Vision Tests ; Biometry
مستخلص: Purpose: The purpose of this study was to evaluate the epidemiology, etiology, clinical assessment, investigation, management, and visual consequences of high myopia (≤-6 diopters [D]) in infants and young children.
Findings: High myopia is rare in pre-school children with a prevalence less than 1%. The etiology of myopia in such children is different than in older children, with a high rate of secondary myopia associated with prematurity or genetic causes. The priority following the diagnosis of high myopia in childhood is to determine whether there is an associated medical diagnosis that may be of greater overall importance to the health of the child through a clinical evaluation that targets the commonest features associated with syndromic forms of myopia. Biometric evaluation (including axial length and corneal curvature) is important to distinguishing axial myopia from refractive myopia associated with abnormal development of the anterior segment. Additional investigation includes ocular imaging, electrophysiological tests, genetic testing, and involvement of pediatricians and clinical geneticists is often warranted. Following investigation, optical correction is essential, but this may be more challenging and complex than in older children. Application of myopia control interventions in this group of children requires a case-by-case approach due to the lack of evidence of efficacy and clinical heterogeneity of high myopia in young children.
Conclusions: High myopia in infants and young children is a rare condition with a different pattern of etiology to that seen in older children. The clinical management of such children, in terms of investigation, optical correction, and use of myopia control treatments, is a complex and often multidisciplinary process.
References: Am J Ophthalmol. 2017 Oct;182:81-89. (PMID: 28751151)
Doc Ophthalmol. 2018 Feb;136(1):1-26. (PMID: 29397523)
Hum Genet. 2015 Apr;134(4):451-3. (PMID: 25663169)
J Cataract Refract Surg. 2004 Jan;30(1):74-84. (PMID: 14967271)
Front Genet. 2021 Jun 23;12:600210. (PMID: 34745198)
J Cataract Refract Surg. 1995 Nov;21(6):630-2. (PMID: 8551439)
Ophthalmology. 2021 Aug;128(8):1188-1196. (PMID: 33387554)
Am J Ophthalmol. 1979 Sep;88(3 Pt 1):506-10. (PMID: 484678)
Ophthalmic Genet. 2021 Feb;42(1):71-74. (PMID: 32940091)
Ophthalmology. 2014 Aug;121(8):1588-97. (PMID: 24793526)
J Cataract Refract Surg. 1997 Jun;23(5):736-9. (PMID: 9278795)
Am J Ophthalmol. 2009 Apr;147(4):573-582.e2. (PMID: 19327445)
Am J Ophthalmol. 1996 Nov;122(5):727-8. (PMID: 8909215)
Ophthalmology. 2010 Jan;117(1):140-147.e3. (PMID: 19926137)
JAMA Ophthalmol. 2014 Nov;132(11):1327-33. (PMID: 25103848)
J Formos Med Assoc. 2021 Dec;120(12):2120-2127. (PMID: 34119394)
Hum Mutat. 2022 Mar;43(3):380-388. (PMID: 35001458)
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M89-M105. (PMID: 30817828)
Am J Ophthalmol. 2022 Mar;235:15-23. (PMID: 34450111)
J AAPOS. 2013 Apr;17(2):124-8. (PMID: 23622444)
Gene. 2016 Oct 10;591(1):279-291. (PMID: 27437668)
Invest Ophthalmol Vis Sci. 2016 Nov 01;57(14):6188-6196. (PMID: 27842160)
Prog Retin Eye Res. 2010 Mar;29(2):144-68. (PMID: 20044062)
Ophthalmology. 1998 Jul;105(7):1292-300. (PMID: 9663236)
Sci Rep. 2019 Mar 5;9(1):3474. (PMID: 30837507)
Acta Ophthalmol Scand. 1996 Jun;74(3):297-300. (PMID: 8828731)
Br J Ophthalmol. 2019 Aug;103(8):1112-1118. (PMID: 30315130)
Eye (Lond). 1992;6 ( Pt 5):477-83. (PMID: 1286710)
Eye (Lond). 2007 Dec;21(12):1473-8. (PMID: 16878114)
Br J Ophthalmol. 2002 Sep;86(9):1035-40. (PMID: 12185134)
Br J Ophthalmol. 2005 Apr;89(4):484-8. (PMID: 15774929)
J Cataract Refract Surg. 2010 Sep;36(9):1486-93. (PMID: 20692559)
Eye (Lond). 2001 Feb;15(Pt 1):70-4. (PMID: 11318301)
JAMA Ophthalmol. 2020 Jan 1;138(1):14-20. (PMID: 31697304)
Prog Retin Eye Res. 2015 Mar;45:58-110. (PMID: 25307992)
Int J Neonatal Screen. 2020 Jul 30;6(3):. (PMID: 33239586)
Ophthalmology. 1998 May;105(5):810-24. (PMID: 9593380)
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1348-55. (PMID: 19933197)
PLoS One. 2017 Nov 9;12(11):e0187396. (PMID: 29121045)
J AAPOS. 2007 Dec;11(6):571-6. (PMID: 17604197)
Ophthalmology. 2006 Feb;113(2):169-76. (PMID: 16360207)
Ophthalmic Physiol Opt. 2016 Jul;36(4):388-94. (PMID: 27350183)
J Cataract Refract Surg. 2000 May;26(5):684-9. (PMID: 10831897)
J AAPOS. 2006 Aug;10(4):357-63. (PMID: 16935238)
J Cataract Refract Surg. 2004 Dec;30(12):2529-35. (PMID: 15617920)
Eur J Ophthalmol. 2021 May;31(3):853-883. (PMID: 33673740)
Invest Ophthalmol Vis Sci. 2022 Jun 1;63(6):15. (PMID: 35704304)
Doc Ophthalmol. 2020 Apr;140(2):95-101. (PMID: 31749034)
Sci Rep. 2020 Aug 25;10(1):14176. (PMID: 32843658)
Invest Ophthalmol Vis Sci. 2002 May;43(5):1686-93. (PMID: 11980891)
Hum Mol Genet. 2022 Sep 29;31(19):3290-3298. (PMID: 35567543)
Indian J Ophthalmol. 2017 Sep;65(9):835-840. (PMID: 28905827)
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M20-M30. (PMID: 30817826)
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):338-348. (PMID: 29346494)
Optom Vis Sci. 2015 Apr;92(4 Suppl 1):S3-9. (PMID: 25756334)
Am Orthopt J. 2002;52:58-68. (PMID: 21149058)
J Pediatr Ophthalmol Strabismus. 1991 May-Jun;28(3):134-6. (PMID: 1890569)
J Clin Med. 2019 Nov 28;8(12):. (PMID: 31795241)
Clin Exp Optom. 2000 Nov-Dec;83(6):330-332. (PMID: 12472425)
Doc Ophthalmol. 2022 Jun;144(3):165-177. (PMID: 35511377)
Ophthalmology. 2016 Aug;123(8):1783-1787. (PMID: 27221735)
Clin Exp Optom. 2019 May;102(3):270-285. (PMID: 30565333)
Clin Genet. 2014 Sep;86(3):282-6. (PMID: 23992033)
Clin Ophthalmol. 2018 Aug 29;12:1581-1587. (PMID: 30214142)
J Cataract Refract Surg. 2008 Mar;34(3):411-6. (PMID: 18299065)
J AAPOS. 2005 Jun;9(3):224-33. (PMID: 15956941)
Optometry. 2005 Feb;76(2):102-14. (PMID: 15732627)
Arch Ophthalmol. 2005 Jul;123(7):991-9. (PMID: 16009843)
Ophthalmology. 1992 Mar;99(3):329-40. (PMID: 1565444)
Int Ophthalmol. 2022 Nov;42(11):3511-3520. (PMID: 35612690)
JAMA Ophthalmol. 2020 Jan 1;138(1):7-13. (PMID: 31670792)
Doc Ophthalmol. 2018 Jun;136(3):199-206. (PMID: 29934802)
Cont Lens Anterior Eye. 2018 Apr;41(2):224-228. (PMID: 28662862)
J Cataract Refract Surg. 2006 Jan;32(1):103-8. (PMID: 16516787)
Doc Ophthalmol. 2021 Feb;142(1):5-16. (PMID: 33492495)
JAMA Ophthalmol. 2016 Dec 01;134(12):1355-1363. (PMID: 27768171)
Cochrane Database Syst Rev. 2020 Jan 13;1:CD004916. (PMID: 31930781)
J Ophthalmol. 2017;2017:6823965. (PMID: 29163989)
Ophthalmology. 1986 Dec;93(12):1593-8. (PMID: 3808618)
Br J Ophthalmol. 2003 Aug;87(8):1025-31. (PMID: 12881349)
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):154-160. (PMID: 30640967)
Br J Ophthalmol. 1994 Aug;78(8):612-4. (PMID: 7918287)
Ophthalmology. 2009 Apr;116(4):739-46, 746.e1-4. (PMID: 19243832)
Br J Ophthalmol. 2009 May;93(5):650-5. (PMID: 19098036)
Mol Vis. 2016 Oct 26;22:1257-1266. (PMID: 27829781)
J Refract Surg. 2002 Sep-Oct;18(5):519-23. (PMID: 12361151)
J AAPOS. 2013 Feb;17(1):4-8. (PMID: 23360915)
Am J Ophthalmol Case Rep. 2018 Jan 10;9:75-76. (PMID: 29577095)
Am J Ophthalmol. 2005 Feb;139(2):259-65. (PMID: 15733986)
Ophthalmol Ther. 2020 Dec;9(4):709-724. (PMID: 32740739)
Eur J Hum Genet. 2019 Mar;27(3):369-377. (PMID: 30568244)
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M184-M203. (PMID: 30817832)
Am J Ophthalmol. 2005 Jun;139(6):1067-72. (PMID: 15953438)
Orphanet J Rare Dis. 2015 Feb 22;10:21. (PMID: 25888220)
J Cataract Refract Surg. 1998 Mar;24(3):327-30. (PMID: 9559467)
Br J Ophthalmol. 2004 Jul;88(7):853-4. (PMID: 15205221)
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):901-906. (PMID: 28159977)
Am J Med Genet A. 2003 Jan 30;116A(3):234-7. (PMID: 12503098)
Clin Ophthalmol. 2015 Dec 21;10:1-6. (PMID: 26730175)
Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2623-2630. (PMID: 31226711)
Retina. 2020 Mar;40(3):399-411. (PMID: 31259808)
J Pediatr Ophthalmol Strabismus. 2019 Nov 1;56(6):383-387. (PMID: 31743407)
Ophthalmic Physiol Opt. 2020 Mar;40(2):230-240. (PMID: 32202320)
Genes (Basel). 2022 Mar 29;13(4):. (PMID: 35456422)
J Cataract Refract Surg. 2002 Jun;28(6):932-41. (PMID: 12036633)
PLoS One. 2020 Nov 20;15(11):e0241759. (PMID: 33216753)
BMC Ophthalmol. 2017 Jun 12;17(1):88. (PMID: 28606071)
Lancet. 2017 Aug 26;390(10097):849-860. (PMID: 28712537)
Acta Ophthalmol. 2018 May;96(3):301-309. (PMID: 29265742)
J Refract Surg. 2001 Sep-Oct;17(5):519-24. (PMID: 11583221)
Optom Vis Sci. 2004 Jan;81(1):11-3. (PMID: 14747755)
J AAPOS. 2005 Apr;9(2):121-8. (PMID: 15838438)
Am J Med Genet. 1986 Jul;24(3):387-92. (PMID: 3728560)
J AAPOS. 2006 Aug;10(4):364-70. (PMID: 16935239)
PLoS One. 2019 Jun 10;14(6):e0218107. (PMID: 31181108)
J AAPOS. 2001 Dec;5(6):348-51. (PMID: 11753253)
JAMA Ophthalmol. 2016 Jul 1;134(7):753-62. (PMID: 27259167)
Eye (Lond). 2014 Sep;28(9):1080-6; quiz 1087. (PMID: 25104736)
Vision Res. 1995 May;35(9):1313-24. (PMID: 7610592)
Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):3. (PMID: 33909035)
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26. (PMID: 28306229)
Transl Vis Sci Technol. 2021 Jul 1;10(8):26. (PMID: 34319387)
PLoS One. 2013 Oct 30;8(10):e78003. (PMID: 24205064)
Adv Exp Med Biol. 2018;1085:65-66. (PMID: 30578487)
Mol Genet Genomic Med. 2020 Sep;8(9):e1354. (PMID: 32578940)
J AAPOS. 2007 Apr;11(2):153-8. (PMID: 17140827)
Acta Ophthalmol (Copenh). 1982 Jun;60(3):403-11. (PMID: 7136552)
Br J Ophthalmol. 1983 Mar;67(3):170-3. (PMID: 6687430)
Surv Ophthalmol. 2007 Nov-Dec;52(6):588-96. (PMID: 18029268)
Retina. 2019 Jun;39(6):1186-1199. (PMID: 29528978)
Int J Ophthalmol. 2017 Oct 18;10(10):1592-1603. (PMID: 29062781)
Clin Exp Optom. 2011 Nov;94(6):514-27. (PMID: 21722183)
Clin Exp Optom. 2020 Mar;103(2):133-137. (PMID: 31854025)
Cesk Slov Oftalmol. 2016 Spring;72(2):12-9. (PMID: 27341094)
J Optom. 2020 Jul - Sep;13(3):146-154. (PMID: 31992534)
Eye (Lond). 2011 Nov;25(11):1389-400. (PMID: 21921955)
Br J Ophthalmol. 1995 Jul;79(7):637-41. (PMID: 7662625)
J Cataract Refract Surg. 2004 Dec;30(12):2522-8. (PMID: 15617919)
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5199-207. (PMID: 19036998)
Ophthalmic Physiol Opt. 2023 May;43(3):494-504. (PMID: 36882953)
J Refract Surg. 1999 Jul-Aug;15(4):429-35. (PMID: 10445714)
Eur J Ophthalmol. 2022 May;32(3):1314-1323. (PMID: 34894815)
تواريخ الأحداث: Date Created: 20230501 Date Completed: 20230503 Latest Revision: 20230512
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10153576
DOI: 10.1167/iovs.64.6.3
PMID: 37126360
قاعدة البيانات: MEDLINE
الوصف
تدمد:1552-5783
DOI:10.1167/iovs.64.6.3